CERO THERAPEUTICS HOLDINGS, INC. Number of Operating Segments
CERO THERAPEUTICS HOLDINGS, INC. (CERO) reported Number of Operating Segments of 1 Segments for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes
us-gaap:NumberOfOperatingSegments · last filed 2026-08-14
- CERO THERAPEUTICS HOLDINGS, INC. number of operating segments for the quarter ending 2026-03-31 was 1.00 Segments.
- CERO THERAPEUTICS HOLDINGS, INC. number of operating segments for fiscal 2025 was 1.00 Segments.
| Period end | Number of Operating Segments 3 month | Number of Operating Segments 6 month | Number of Operating Segments 12 month |
|---|---|---|---|
| 2026-06-30 | 1.00 Segments 10-Q · filed 2026-08-14 | ||
| 2026-03-31 | 1.00 Segments 10-Q · filed 2026-05-15 | ||
| 2025-12-31 | 1.00 Segments 10-K · filed 2026-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |